Lifeline for ‘antibiotic of last resort’ unveiled
April 12th, 2010 - 5:11 pm ICT by ANILondon, Apr 12 (ANI): For the first time, researchers at Michael G. DeGroote Institute for Infectious Disease Research, have uncovered how bacteria recognize and develop resistance to a powerful antibiotic used to treat superbug infections.
Led by Gerry Wright, a professor in the Department of Biochemistry and Biomedical Sciences at McMaster University, the researchers have identified the specific mechanism that triggers resistance to vancomycin.
The discovery reveals new understanding about what is happening at the molecular level in vancomycin resistance.
It also represents an essential first step in developing new antibiotics that can evade the sensing mechanism of bacteria and overcome resistance.
“Vancomycin is the antibiotic of last resort and is only given when all other treatments fail,” said Wright.
“For years it was thought that resistance would be slow to emerge since vancomycin works in an unusual way. But with the widespread use of the drug to treat infections caused by the hospital superbug MRSA, it has become a serious clinical problem,” he added
MRSA is the short-form for methicillin-resistant staphylococcus aureus, a bacterial infection that is highly resistant to some antibiotics.
MRSA bacteria are responsible for a large percentage of hospital-acquired staph infections, but may also be acquired in the community.
Vancomycin is used to treat enterococcal infections that develop in patients following abdominal surgery.
For 20 years, scientists around the world have debated whether bacteria sense the drug itself to trigger resistance or whether they sense the impact it has on the cell wall of bacteria.
Most antibiotics work by inhibiting an enzyme but vancomycin binds to cell wall building blocks, causing a weakness in the structure of the cell wall so the cell bursts and dies.
The researchers studied the vancomycin-resistance mechanism in the harmless soil bacteria Streptomyces coelicolor.
The scientists showed that bacteria detect vancomycin itself.
They also conducted preliminary experiments that suggest the same mechanism exists in disease causing bacteria.
“We have finally cracked the alarm system used by bacteria, and hopefully new antibiotics can be developed that don’t set it off,” said Mark Buttner, a study collaborator and senior scientist at the John Innes Centre.
The study has been published online in the high-impact journal Nature Chemical Biology. (ANI)
- Nanostructures lend cutting edge to antibiotics - Apr 04, 2011
- Scientists crack secret of superbug's resistance - Apr 29, 2011
- Harvard team crack superbugs' genetic code - May 23, 2012
- Now, antibiotics to combat drug-resistant 'superbugs' - Sep 15, 2010
- Unique coating kills 99 percent bugs - May 11, 2012
- Scientists one step closer to developing vaccine for MRSA - Jan 17, 2011
- New compound found effective against resistant microbes - May 28, 2010
- Combination therapy shows promise in treating devastating cystic fibrosis - Apr 25, 2011
- Bacterial 'genome mining' produces new drugs - Aug 02, 2010
- Now, drug that kills deadly superbugs within 5 minutes - Sep 19, 2010
- Infectious bugs alter DNA to become resistant - Nov 14, 2011
- Cockroaches could help combat E.coli - Sep 05, 2010
- Copper wins out in battle against MRSA - Apr 05, 2011
- Novel nanotechnology paves way for effective anti-superbug drugs - Oct 13, 2008
- Antibiotic dosing guidelines to help counteract superbugs - Jul 05, 2011
Tags: abdominal surgery, antibiotic, bacterial infection, biomedical sciences, cell wall of bacteria, degroote, department of biochemistry, hospital superbug, infectious disease research, last resort, mcmaster university, mrsa, new antibiotics, resistant staphylococcus aureus, soil bacteria, structure of the cell, time researchers, unusual way, vancomycin, vancomycin resistance